Search Results - "Froehlich, Thomas W"

Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients by Frankel, Arthur E., Coughlin, Laura A., Kim, Jiwoong, Froehlich, Thomas W., Xie, Yang, Frenkel, Eugene P., Koh, Andrew Y.

“…This is the first prospective study of the effects of human gut microbiota and metabolites on immune checkpoint inhibitor (ICT) response in metastatic melanoma…”
Get full text

Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients by Frankel, Arthur E, Eskiocak, Ugur, Gill, Jennifer G, Yuan, Stacy, Ramesh, Vijayashree, Froehlich, Thomas W, Ahn, Chul, Morrison, Sean J

“…Abstract This is the first prospective study of a combination therapy involving a cardenolide and a MEK inhibitor for metastatic melanoma. Whereas BRAF mutant…”
Get full text

Safety and outcomes of a cancer patient urgent care clinic by Bevins, Jack S, Fullington, Hannah, Froehlich, Thomas W., Hobbs, Stephanie, Halm, Ethan, Lee, Simon Craddock, Hong, Arthur

“…Abstract only 6542 Background: Several cancer centers describe cancer-patient dedicated urgent care clinic (UCC) that address commonly anticipated complaints…”
Get full text

Digoxin plus trametinib therapy of BRAF wild type metastatic melanoma patients by Frankel, Arthur E., Eskiocak, Ugur, Froehlich, Thomas W., Ahn, Chul, Hoelscher, Amanda Joy, Morrison, Sean

“…Abstract only…”
Get full text

Metagenomic shotgun sequencing to identify specific human gut microbes associated with immune checkpoint therapy efficacy in melanoma patients by Frankel, Arthur E., Froehlich, Thomas W., Kim, Jiwoong, Coughlin, Laura A., Xie, Yang, Frenkel, Eugene P., Koh, Andrew Y.

“…Abstract only 9516 Background: Immune checkpoint inhibitor therapy, ICT, achieves durable remissions in 30-50% of patients (pts) with metastatic melanoma…”
Get full text

Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients1 by Frankel, Arthur E., Coughlin, Laura A., Kim, Jiwoong, Froehlich, Thomas W., Xie, Yang, Frenkel, Eugene P., Koh, Andrew Y.

“…This is the first prospective study of the effects of human gut microbiota and metabolites on immune checkpoint inhibitor (ICT) response in metastatic melanoma…”
Get full text

Development of a nutrition-focused quality improvement program for new patients with cancer seen at the UTSW Simmons Comprehensive Cancer Center (SCCC) outpatient gastrointestinal (GI) oncology clinic by Brown, Timothy J, Wolfe, Heather R, Hardy, Shelli, Bhulani, Nizar, Hong, Christine, Khosama, Leticia, Cheedella, Naga, Hobbs, Stephanie, Froehlich, Thomas W., Kamal, Arif, Beg, Muhammad Shaalan, Kazmi, Syed Mohammad Ali

“…Abstract only 143 Background: Patients with GI malignancies suffer from weight loss, sarcopenia and malnutrition contributing to poor outcomes and reduced…”
Get full text

Terminal Deoxynucleotidyl Transferase-Containing Cells in Peripheral Blood: Implications for the Surveillance of Patients With Lymphoblastic Leukemia or Lymphoma in Remission by Froehlich, Thomas W., Buchanan, George R., Cornet, Jo Ann M., Sartain, Peggy A., Smith, R. Graham

“…An indirect immunofluorescence assay was used to quantitate TdT-containing (TdT+) cells in the mononuclear leukocyte fraction of peripheral blood from normal…”
Get full text